These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22174154)

  • 1. ECSASB2 mediates MLL degradation during hematopoietic differentiation.
    Wang J; Muntean AG; Hess JL
    Blood; 2012 Feb; 119(5):1151-61. PubMed ID: 22174154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.
    Heuzé ML; Guibal FC; Banks CA; Conaway JW; Conaway RC; Cayre YE; Benecke A; Lutz PG
    J Biol Chem; 2005 Feb; 280(7):5468-74. PubMed ID: 15590664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases.
    Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A
    Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
    Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
    Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
    Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
    Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
    Popovic R; Riesbeck LE; Velu CS; Chaubey A; Zhang J; Achille NJ; Erfurth FE; Eaton K; Lu J; Grimes HL; Chen J; Rowley JD; Zeleznik-Le NJ
    Blood; 2009 Apr; 113(14):3314-22. PubMed ID: 19188669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells.
    Yang Z; Augustin J; Chang C; Hu J; Shah K; Chang CW; Townes T; Jiang H
    Blood; 2014 Sep; 124(13):2025-33. PubMed ID: 25139354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Mll-dependent Hox program drives hematopoietic progenitor expansion.
    Ernst P; Mabon M; Davidson AJ; Zon LI; Korsmeyer SJ
    Curr Biol; 2004 Nov; 14(22):2063-9. PubMed ID: 15556871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
    Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
    J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.
    El Ashkar S; Schwaller J; Pieters T; Goossens S; Demeulemeester J; Christ F; Van Belle S; Juge S; Boeckx N; Engelman A; Van Vlierberghe P; Debyser Z; De Rijck J
    Blood; 2018 Jan; 131(1):95-107. PubMed ID: 29084774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of menin in hematopoiesis.
    Maillard I; Hess JL
    Adv Exp Med Biol; 2009; 668():51-7. PubMed ID: 20175452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
    Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
    Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
    Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.
    Chen J; Santillan DA; Koonce M; Wei W; Luo R; Thirman MJ; Zeleznik-Le NJ; Diaz MO
    Cancer Res; 2008 Aug; 68(15):6199-207. PubMed ID: 18676843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PHD fingers of MLL block MLL fusion protein-mediated transformation.
    Muntean AG; Giannola D; Udager AM; Hess JL
    Blood; 2008 Dec; 112(12):4690-3. PubMed ID: 18796627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
    Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
    Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
    Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
    Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.